fda approved weight loss glp-1 Is Semaglutide Safe for Loss? Wegovy Pill Wins FDA Approval

Weight loss is not only about the number on the scale

Tirzepatide studies showed only 2.4% of participants developed type 2 diabetes, compared to 13.7% taking placebo 7

Many of these side effects lessen with time as your body adjusts to the medication

What is still unknown is how many people who cycle off GLP-1 drugs ultimately end up returning to their pre-GLP-1 lifestyle and eating habits

Journal of Clinical Endocrinology & Metabolism , 105(4), 1023-1035

The pathogenesis originates from an imbalance in hepatic lipid homeostasis, where excessive triglyceride accumulation results from increased lipid influx, enhanced de novo lipogenesis, and impaired lipid export or oxidation